about
Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery diseaseMeta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrationsLack of association between dietary fructose and hyperuricemia risk in adultsHuman sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urateThe genetics of hyperuricaemia and goutUrate Handling in the Human BodyThe discovery of hypertension: evolving views on the role of the kidneys, and current hot topicsThe effects of diabetes on male fertility and epigenetic regulation during spermatogenesisNatural Products Improving Hyperuricemia with Hepatorenal Dual EffectsHuman metabolic individuality in biomedical and pharmaceutical researchMutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemiaUric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese populationRedefining metabolic syndrome as a fat storage condition based on studies of comparative physiologyGenome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.Oscillatory glucose flux in INS 1 pancreatic β cells: a self-referencing microbiosensor study.Homozygous SLC2A9 mutations cause severe renal hypouricemia.Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family.Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentrationLeucophores are similar to xanthophores in their specification and differentiation processes in medaka.Interactions between genetic variants in glucose transporter type 9 (SLC2A9) and dietary habits in serum uric acid regulation.The genetics of gout: towards personalised medicine?A genome-wide association study of serum uric acid in African Americans.Comparison of human solute carriersEffects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Fasting plasma glucose and serum uric acid levels in a general Chinese population with normal glucose tolerance: A U-shaped curve.Uric acid transport and diseaseThe SLC2 (GLUT) family of membrane transporters.HYPEST study: profile of hypertensive patients in Estonia.Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male population.Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.Serum uric acid levels are associated with polymorphism in the SAA1 gene in Chinese subjects.Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients.SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuriaChanges in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish Obese Subjects StudyMendelian randomization of serum urate and parkinson disease progression.Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout.Gout: a review of nonmodifiable and modifiable risk factors.Validation of a urine test and characterization of the putative genetic mutation for hyperuricosuria in Bulldogs and Black Russian TerriersUrate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.
P2860
Q21091170-C645612C-39C1-4324-B16F-894EC1695971Q21092458-C763ADDA-A655-4D45-B11F-EF88D9574702Q21245062-78799FBD-BC15-41C6-A8B7-78173BD5CAD7Q24298283-4848A541-CCD3-4410-9730-24CD61202EA0Q24629964-418FE0EE-E41F-4F39-B593-6383926E4EE7Q26750896-DC2965F0-6657-43D0-8D8C-BFEBA40208F5Q26830489-4ED03A69-55D0-49FD-8A58-8858B30F6DA6Q26998600-FC8968DA-3D7C-4379-9236-097D2292EE26Q28079286-1C587D60-2480-4233-BC4B-B029B0C1ABD6Q28247002-284407FB-9382-45B7-919F-6A237CAD9873Q28301600-4816CBCC-2C67-41BC-97AB-2FE836FB43D3Q28547672-11E1E659-067C-4299-B1E1-B48E723883ECQ28687768-B3D08725-6DC9-4A01-84B5-72808F2D99EFQ30424538-D9E34A9F-FA6A-4667-B198-92C906A22F00Q30499833-223F40C9-13DD-414F-9625-6295EFAD4C64Q33562215-6D6B2A55-4303-46F2-A2E2-4801D136FC86Q33582833-015E7F31-661B-4505-A1B6-1CDCE8CC5532Q33610209-FF801EAC-798C-4C8D-9B81-8B14BF451BA2Q33665327-2DDBC783-C9D9-49A8-A57A-3779B4829AEAQ33690663-0E782942-3DB1-419A-A756-53BF2C5CE969Q33750522-36CFA56D-EC70-4924-906A-7C6E9695CBB5Q33812108-34522604-7DEB-42F5-81E8-27632E3CF194Q33836276-0CB1B1D6-A051-4DB7-A93C-C248542D55A6Q33845734-AE315DED-EFE8-4528-84F9-6AFFD98202BEQ33848499-520F068E-E2FE-4E2E-BE36-FB4B3E338A3EQ33882958-033B8B8F-7A37-4EC2-AD5B-8E04CB6A674BQ33926133-D7F1FCB3-78DA-4F39-A607-195916278D9CQ34006488-C9DBDC34-ED99-409C-8ECE-68F1828C1064Q34185594-E657E45E-33CF-4D38-B47A-8B4A2D637CF0Q34227891-45E1ED25-E6E0-40B0-A134-F096C32EACACQ34328823-42B6599B-84D8-4CF8-99F3-45A92E994AB1Q34466813-AE0ED7CB-F11D-4158-AC0E-34D4E90C1020Q34470786-E1519982-79C2-4658-A3AB-D7DAB6514540Q34525471-A2DEE0F7-71DB-42D8-8F27-D2BC35B6C42BQ34576895-35FDAAC4-8362-4EC9-958A-24DC97E6B10AQ34607608-20EEB26C-8D4A-4DB1-A941-9D2621A36185Q34609600-0EBF3E05-BB88-417A-B1DB-DE370C822315Q34622056-16AC1E02-C166-4D8F-AA8C-A738FE3BC3E6Q34629589-505D8413-0302-47A6-B383-00B38858BF66Q34734573-B7EEEB87-1EC1-4A3B-985A-3BDB9050A0B5
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
SLC2A9 is a high-capacity urate transporter in humans
@ast
SLC2A9 is a high-capacity urate transporter in humans
@en
SLC2A9 is a high-capacity urate transporter in humans
@nl
type
label
SLC2A9 is a high-capacity urate transporter in humans
@ast
SLC2A9 is a high-capacity urate transporter in humans
@en
SLC2A9 is a high-capacity urate transporter in humans
@nl
prefLabel
SLC2A9 is a high-capacity urate transporter in humans
@ast
SLC2A9 is a high-capacity urate transporter in humans
@en
SLC2A9 is a high-capacity urate transporter in humans
@nl
P2093
P2860
P50
P3181
P1433
P1476
SLC2A9 is a high-capacity urate transporter in humans
@en
P2093
Abiodun Onipinla
Chris Cheeseman
Deb O'Neill
Eric Brunner
Gudrun Veldre
Jaspal Kooner
John Chambers
John M Connell
Kate Witkowska
Kelle H Moley
P2860
P3181
P356
10.1371/JOURNAL.PMED.0050197
P407
P50
P577
2008-10-07T00:00:00Z